{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "epsTrailingTwelveMonths": -0.51, "sharesOutstanding": 19521200, "bookValue": 2.991, "fiftyDayAverage": 5.8709, "fiftyDayAverageChange": -0.37090015, "fiftyDayAverageChangePercent": -0.06317603, "twoHundredDayAverage": 5.722555, "twoHundredDayAverageChange": -0.22255516, "twoHundredDayAverageChangePercent": -0.038890872, "marketCap": 109717296, "priceToBook": 1.8388499, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Newbury Pharmaceuticals AB", "nameChangeDate": "2023-05-14", "tradeable": false, "cryptoTradeable": false, "currency": "SEK", "financialCurrency": "SEK", "regularMarketOpen": 5.52, "averageDailyVolume3Month": 36129, "averageDailyVolume10Day": 26637, "fiftyTwoWeekLowChange": 1.9000001, "fiftyTwoWeekLowChangePercent": 0.5277778, "fiftyTwoWeekRange": "3.6 - 8.424", "fiftyTwoWeekHighChange": -2.9239998, "fiftyTwoWeekHighChangePercent": -0.3471035, "fiftyTwoWeekLow": 3.6, "fiftyTwoWeekHigh": 8.424, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1643961600000, "priceHint": 2, "marketState": "REGULAR", "regularMarketChange": 0.01999998, "regularMarketTime": 1684138128, "regularMarketDayHigh": 5.52, "regularMarketDayRange": "5.5 - 5.52", "regularMarketDayLow": 5.5, "regularMarketVolume": 5800, "regularMarketPreviousClose": 5.48, "bid": 5.48, "ask": 5.6, "fullExchangeName": "Stockholm", "regularMarketChangePercent": 0.36496314, "regularMarketPrice": 5.5, "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "STO", "shortName": "Newbury Pharmaceuticals AB", "longName": "Newbury Pharmaceuticals AB (publ)", "messageBoardId": "finmb_695083866", "market": "se_market", "symbol": "NEWBRY.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Scheeletorget 1", "address2": "Medicon Village", "city": "Lund", "zip": "223 81", "country": "Sweden", "phone": "46 46 12 11 20", "website": "https://www.newburypharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Newbury Pharmaceuticals AB (publ), a pharmaceutical company, produces and commercializes in-licensed specialty prescription drugs in Sweden, Denmark, Norway, and other Scandinavian countries. It offers oncology drugs, such as Lenalidomide, Sunitinib, Pazopanib, Lapatinib, Bosutinib, Lenvatinib, Enzalutamide, Nilotinib, Pomalidomide, Palbociclib, and Nintedanib; drugs for rare diseases, including Icatibant, Macitentan, Pirfenidone, and Teduglutide; neurology drugs, which include dimetylfumarat, lorazepam ER, teriflunomide, and fampridine; and drugs for various other therapeutic areas comprising Solifenacin + Tamsulosin, Liraglutide, Desmopressin ODT, Gabapentin ER, Rivaroxaban, Ticagrelor, Tofacitinib, and Varenicline. The company was incorporated in 2020 and is based in Lund, Sweden.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Mr. Karl  Karlsson", "age": 48, "title": "Founder & Exec. Chairman", "yearBorn": 1974, "fiscalYear": 2021, "totalPay": {"raw": 1319481, "fmt": "1.32M", "longFmt": "1,319,481"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Christoffer  Tell", "age": 35, "title": "Chief Financial Officer", "yearBorn": 1987, "fiscalYear": 2021, "totalPay": {"raw": 0, "fmt": null, "longFmt": "0"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fredrik  Hellqvist", "age": 49, "title": "VP of Sales & Marketing", "yearBorn": 1973, "fiscalYear": 2021, "totalPay": {"raw": 601848, "fmt": "601.85k", "longFmt": "601,848"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lars  Minor", "age": 52, "title": "Chief Exec. Officer", "yearBorn": 1970, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Andrea  Karnitschky", "title": "Sr. Director & Head of Bus. Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}